Citation Impact
Citing Papers
Drug Resistance inMycobacterium tuberculosis
2006
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Comprehensive identification of conditionally essential genes in mycobacteria
2001
Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe
2018 StandoutNobel
Otitis externa in UK general practice: a survey using the UK General Practice Research Database.
2001
Genes required for mycobacterial growth defined by high density mutagenesis
2003 Standout
In silico prediction of protein-protein interactions in human macrophages
2014 Standout
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Paper-based microfluidic point-of-care diagnostic devices
2013 Standout
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response
2009
A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy
2009 Standout
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 Standout
Tuberculosis
2015
The burden of non-communicable diseases in South Africa
2009 Standout
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
2010
The clinical consequences of strain diversity in Mycobacterium tuberculosis
2008
Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
2009
Identification and structural characterization of an unusual mycobacterial monomeromycolyl‐diacylglycerol
2005
Gold on paper–paper platform for Au-nanoprobe TB detection
2012
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols
2021 StandoutNobel
Elucidation and Chemical Modulation of Sulfolipid-1 Biosynthesis in Mycobacterium tuberculosis
2011 StandoutNobel
Antituberculosis drugs: Ten years of research
2007
TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy
2019 Standout
Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture
2019
SuFExable polymers with helical structures derived from thionyl tetrafluoride
2021 StandoutNobel
A Conserved Mechanism for Sulfonucleotide Reduction
2005 StandoutNobel
The Regulation of Sulfur Metabolism in Mycobacterium tuberculosis
2011 StandoutNobel
EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator
2003
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Triclosan Derivatives: Towards Potent Inhibitors of Drug‐Sensitive and Drug‐Resistant Mycobacterium tuberculosis
2009
Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum
2019 StandoutNobel
An Expanded Set of Fluorogenic Sulfatase Activity Probes
2014 StandoutNobel
Sensitivity optimisation of tuberculosis bioaerosol sampling
2020 StandoutNobel
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
2010
Substrate Recognition, Protein Dynamics, and Iron-Sulfur Cluster in Pseudomonas aeruginosa Adenosine 5′-Phosphosulfate Reductase
2006 StandoutNobel
Face Mask Sampling for the Detection of Mycobacterium tuberculosis in Expelled Aerosols
2014
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2010 Standout
Confronting the scientific obstacles to global control of tuberculosis
2008
Opportunities and Challenges for HIV Care in Overlapping HIV and TB Epidemics
2008
Molecular detection, identification and drug resistance detection inMycobacterium tuberculosis: Table 1
2009
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
The health and health system of South Africa: historical roots of current public health challenges
2009 Standout
Synthetic EthR inhibitors boost antituberculous activity of ethionamide
2009
Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux
2011
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
1996 Standout
Catalytic Asymmetric Synthesis of Phthioceranic Acid, a Heptamethyl-Branched Acid from Mycobacterium tuberculosis
2007 StandoutNobel
Extensively Drug-Resistant Tuberculosis: A New Face to an Old Pathogen
2009
Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities
2011
Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
2009
Multidimensional SuFEx Click Chemistry: Sequential Sulfur(VI) Fluoride Exchange Connections of Diverse Modules Launched From An SOF4 Hub
2017 StandoutNobel
Biological Activities of Hydrazone Derivatives
2007 Standout
Cooperative capture synthesis: yet another playground for copper-free click chemistry
2016 StandoutNobel
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Effect of Essential Oils on Pathogenic Bacteria
2013 Standout
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
ideR , an Essential Gene in Mycobacterium tuberculosis : Role of IdeR in Iron-Dependent Gene Expression, Iron Metabolism, and Oxidative Stress Response
2002
A fluorogenic screening platform enables directed evolution of an alkyne biosynthetic tool
2016 StandoutNobel
Hygiene for hydrotherapy pools
1986
THE MAGIC BULLETS AND TUBERCULOSIS DRUG TARGETS
2004
Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug Discovery
2001
The Immune Response in Tuberculosis
2013 Standout
How research can help control tuberculosis.
2009
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Point-of-Care Diagnostics for Global Health
2008 Standout
Noncovalent complexes of APS reductase from M. tuberculosis: Delineating a mechanistic model using ESI-FTICR MS
2006 StandoutNobel
Genetic requirements for mycobacterial survival during infection
2003 Standout
Diversity Oriented Clicking (DOC): Divergent Synthesis of SuFExable Pharmacophores from 2‐Substituted‐Alkynyl‐1‐Sulfonyl Fluoride (SASF) Hubs
2020 StandoutNobel
Fluorosulfuryl Isocyanate Enabled SuFEx Ligation of Alcohols and Amines
2021 StandoutNobel
Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
2008
The Halogen Bond
2016 Standout
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling
2007 StandoutNobel
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Discovery of sulfated metabolites in mycobacteria with a genetic and mass spectrometric approach
2002 StandoutNobel
Works of M Bosman being referenced
Population Structure of Mixed Mycobacterium tuberculosis Infection Is Strain Genotype and Culture Medium Dependent
2013
Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa
2008
Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients.
2006
Otitis externa byPseudomonas aeruginosaassociated with whirlpools
1983
Ethambutol resistance testing by mutation detection.
2006
Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis
2007
Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa.
2007
The Diagnostic Performance of the GenoType MTBDR plus Version 2 Line Probe Assay Is Equivalent to That of the Xpert MTB/RIF Assay
2012
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
2000
inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa?
2011